SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-20-010464
Filing Date
2020-06-03
Accepted
2020-06-03 15:48:46
Documents
5
Period of Report
2020-05-22
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm 8-K/A 30772
2 ex16-1.htm EX-16.1 45759
3 ex16-1_001.jpg GRAPHIC 1739
4 ex16-1_002.jpg GRAPHIC 12957
5 ex16-1_004.jpg GRAPHIC 19334
  Complete submission text file 0001493152-20-010464.txt   125113
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37428 | Film No.: 20939850
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences